Oman Investment Authority has announced an investment in Neuralink, the US-based brain-computer interface company, marking a strategic move into one of the world’s most closely watched areas of future medical technology.

The investment forms part of OIA’s broader approach to diversifying its international portfolio and increasing its exposure to high-impact technologies, particularly in healthcare, deep technology and advanced innovation-led sectors.

Neuralink is regarded as one of the leading companies in the field of brain-computer interfaces, or BCI. The company is developing highly precise neural implants designed to be placed in the brain, enabling direct communication between human neural activity and digital devices. The technology is being developed with the aim of supporting people affected by serious neurological conditions and restoring certain levels of independence through digital control.

Brain-computer interface technologies are designed to bypass traditional sensory or motor pathways by translating brain signals into digital commands. This has significant implications for patients who have lost mobility due to strokes, spinal cord injuries or neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, commonly known as ALS. In many such cases, cognitive function remains intact while the body’s ability to move or communicate is severely affected.

Neural devices, including brain implants, could allow patients to perform tasks such as typing, moving a cursor or controlling external devices using neural signals. Recent clinical trial outcomes have demonstrated the potential of this technology, with Neuralink’s first human patient reportedly able to control a computer and type using thought alone. These developments point to the possible role of such technologies in improving quality of life for patients with complex neurological disorders.

OIA’s investment reflects its focus on sectors that are expected to shape the future of global healthcare. Neuralink has received official approvals to conduct human clinical trials in the United States, using advanced robotic surgical systems to support the implantation of its devices with high levels of precision.

According to OIA, Neuralink has implanted its neural devices in 21 patients as of January 2026, including 17 procedures carried out during 2025. This reflects the growing pace of clinical activity and the expansion of the company’s trial programme.

The company is also working closely with regulatory authorities and participating hospitals to improve its devices and maintain safety standards as clinical trials progress. OIA noted that Neuralink has not recorded serious device-related adverse events to date, a factor that has contributed to the widening of its clinical trial participant programme from three participants in 2024 to multiple participants per month during 2025.

Beyond motor and communication support, Neuralink is also developing a project known as “Blindsight,” a neural visual prosthesis concept aimed at restoring a form of vision by stimulating the brain’s visual cortex through digital camera inputs. The project’s name draws from a neuroscience concept linked to visual perception, where individuals may respond to visual stimuli without full conscious awareness. Human trials are planned for the future, with early versions expected to offer low-resolution visual perception that could improve as the technology develops.

Neuralink’s operating model is also a key part of its growth strategy. The company follows a vertically integrated structure, managing major areas of development internally, including research and development, implant manufacturing, robotic surgery systems, neuroengineering and specialised surgical teams. This model is designed to accelerate innovation, improve control over safety and quality, and support the company’s long-term ambitions for scalable production.

For Oman Investment Authority, the investment represents another step in building exposure to future-facing industries with long-term economic and technological relevance. OIA’s investments are currently spread across more than 52 countries, in line with its strategy to diversify its portfolio, strengthen global partnerships and support Oman’s broader goals of financial sustainability and economic diversification.